Core Viewpoint - The China Securities Regulatory Commission (CSRC) has released a report on the status of domestic companies' overseas securities issuance and listing applications, indicating several companies are in various stages of the IPO process in Hong Kong [1]. Group 1: Companies and Their IPO Status - Sifang Precision (300468.SZ) has submitted materials for a Hong Kong IPO and has received acceptance from the CSRC [1][2]. - Zhenqu Technology is also in the process of applying for a Hong Kong IPO, with materials accepted by the CSRC [1][2]. - Jingze Biopharmaceutical (Hefei) has its Hong Kong IPO application in a supplementary materials status [1][2]. - Weili Zhibo-B (09887) has received acceptance for its full circulation application from the CSRC [1][2]. - Lingbao Gold's full circulation application is currently in a supplementary materials status [1][2]. Group 2: Application Details - Lingbao Gold Group's full circulation application was received on January 13, 2026, and is in supplementary materials status [2]. - Sifang Precision's direct overseas listing application was accepted on January 14, 2026, with the underwriting by CMB International and Guosen Securities [2]. - Weili Zhibo's full circulation application was also accepted on January 14, 2026, with legal representation from JunHe Law Offices [2]. - Beijing Extreme Intelligence Technology's full circulation application is in supplementary materials status as of January 16, 2026 [2]. - Jingze Biopharmaceutical's direct overseas listing application is in supplementary materials status as of January 16, 2026, with underwriting by CICC and legal representation from Tian Yuan Law Firm [2]. - Zhenqu Technology's direct overseas listing application was accepted on January 16, 2026, with underwriting by CITIC Securities [2].